Danaher
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Danaher 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About DHR
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics.
CEORainer M. Blair
CEORainer M. Blair
Employees63,000
Employees63,000
HeadquartersWashington, District of Columbia
HeadquartersWashington, District of Columbia
Founded1984
Founded1984
Employees63,000
Employees63,000
DHR Key Statistics
Market cap135.68B
Market cap135.68B
Price-Earnings ratio36.78
Price-Earnings ratio36.78
Dividend yield0.60%
Dividend yield0.60%
Average volume3.45M
Average volume3.45M
High today$195.56
High today$195.56
Low today$189.33
Low today$189.33
Open price$194.96
Open price$194.96
Volume4.52M
Volume4.52M
52 Week high$281.70
52 Week high$281.70
52 Week low$171.00
52 Week low$171.00
DHR News
TipRanks 2d
Danaher Approves Key Proposals at Shareholder MeetingThe latest update is out from Danaher ( (DHR) ). On May 6, 2025, Danaher Corporation held its annual shareholder meeting where key proposals were voted on, inc...
Simply Wall St 4d
Danaher Declares US$0.32 Quarterly Dividend Paymentrecently affirmed a quarterly dividend of $0.32 per share, set for payout in July. Over the past month, the company's share price rose by 5%, reflecting a posit...
Simply Wall St 4d
Danaher Corporation's Popularity With Investors Is ClearWith a price-to-earnings (or "P/E") ratio of 36.1x Danaher Corporation ( ) may be sending very bearish signals at the moment, given that almost half of all comp...
Analyst ratings
90%
of 30 ratingsBuy
90%
Hold
10%
Sell
0%
People also own
Based on the portfolios of people who own DHR. This list is generated using Robinhood data, and it’s not a recommendation.